Website Logo

Our People

Our people are the engine that drives our organizational success and we are a team that makes a difference, powering an inclusive future for all. Our leadership team embodies our values while encouraging every individual to realize their potential with us.

Executive leadership team

Tom Watson

Chief Executive Officer

For the past decade, Tom has partnered with Pharma and Biotech companies to develop global programs, providing patients with access to treatments that would otherwise be unavailable to them. During this time, he has been involved in setting up and running over 300 regional and global EAPs. He has over 20 years’ experience of leading a wide range of global pre-launch and launch activities for treatments addressing areas of high unmet medical need.

Carl Hvass

Chief Financial Officer

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed scelerisque ante eleifend nisi lacinia, eget vehicula sapien fringilla. Fusce sit amet vulputate augue, sit amet consectetur risus. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Vivamus bibendum faucibus semper. Morbi luctus et ante ac aliquam. Donec eget elementum sapien, tincidunt vestibulum lacus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ullamcorper sed massa sed.

Ian Fraser

Chief Operating Officer

Roseanne Day

Chief Legal Officer

Roseanne leads our hardworking, dedicated Legal Team at Bionical Emas. She works collaboratively across the business to ensure that all our activities' legal and regulatory platforms are robust and safe. This includes Bionical Emas’ employees and clients, as well as our patients. She has been an integral part of our ongoing expansion as an innovative business.

John Efthimiou

Chief Medical Officer

John is responsible for providing medical leadership and oversight for Bionical Emas’ clinical development studies, Early Access Programs and corporate medical matters. John is a board certified/specialist accredited physician trained in London and Oxford university hospitals, with wide clinical experience in the care of patients, including those with cancer, and respiratory, infectious and rare diseases. He has over 25 years of global drug development experience in senior medical and R&D roles (CMO, SVP, Exec VP), in and advising la

Liz Boulton

Vice President, Human Resources

Jen Otto

Executive Vice President, Clinical Development

Tom White

Executive Vice President, Clinical Trial Supply

Ellie Matthews

Executive Vice President, Early Access Programs

Behrad Behmardi

Executive Vice President, Information Technology

Graham Sidorowicz

Executive Vice President, Commercial

Caroline Stanton

Senior Vice President, Quality Assurance

Katie Clayton

Vice President, Marketing

Jo Elsden

Vice President, Pharmacovigilance

Cath Lawrence

Vice President, Rare Disease